EUVIMEDEUVIMED entdecken
Crossref

HLM006474-mediated E2F1 inhibition suppresses fibrogenic activation in hepatic stellate cells: a preliminary in vitro study

Nguyen-Anh Tu Le, Truc Luan Le, Duy Anh Lam, Luu-Thao Uyen Nguyen, Hai Nhung Truong

Research Journal of Biotechnology · 31.10.2026 · 1

DOI: 10.25303/2112rjbt01009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Research Journal of Biotechnology, online erschienen am 31.10.2026. Verfasst von Nguyen-Anh Tu Le und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study investigated the role of E2F1 in hepatic stellate cell (HSC) activation and fibrogenic gene expression by evaluating the effects of E2F1 inhibition. HLM006474(HLM), an E2F1 inhibitor, was applied to NIH/3T3 and HepG2 cells for 36 h and to Col-GFPHSC cells for 48 h. Cell proliferation was assessed using CCK-8 assays. The mRNA expression levels of αsma, e2f1 and e2f3 were quantified by RT-qPCR. Protein expression of E2F1 was further examined using immunocytochemistry and Western blot analysis while α-SMA expression was evaluated by ICC staining. Col-GFP-HSC cells were activated with TGF-β (5 ng/mL) to induce fibrogenic responses prior to HLM treatment. HLM inhibited cell proliferation in a dose- and timedependent manner with IC₅₀ values of 19.48 ± 6 μM (NIH/3T3), 71.14 ± 6 μM (HepG2) and 48.67 ± 3 μM (Col-GFP-HSC). In NIH/3T3 cells, HLM increased e2f1 mRNA but reduced E2F1 protein. In Col-GFPHSC cells, HLM reduced both E2F1 and α-SMA expression and significantly suppressed fibrogenic marker expression in TGF-β-activated cells. HLM006474-mediated inhibition of E2F1 suppresses fibrogenic responses in HSCs, particularly through reduced α-SMA expression. These findings indicate that E2F1 functions as a potential regulator of HSCs activation and may represent a therapeutic target for liver fibrosis.

Zitieren

APA

Le, N. T., Le, T. L., Lam, D. A., Nguyen, L. U., & Truong, H. N. (2026). HLM006474-mediated E2F1 inhibition suppresses fibrogenic activation in hepatic stellate cells: a preliminary in vitro study. Research Journal of Biotechnology, 1. https://doi.org/10.25303/2112rjbt01009

Vancouver

Le NT, Le TL, Lam DA, Nguyen LU, Truong HN. HLM006474-mediated E2F1 inhibition suppresses fibrogenic activation in hepatic stellate cells: a preliminary in vitro study. Research Journal of Biotechnology. 2026:1. doi:10.25303/2112rjbt01009

BibTeX
@article{Le2026,
  author = {Le, Nguyen-Anh Tu and Le, Truc Luan and Lam, Duy Anh and Nguyen, Luu-Thao Uyen and Truong, Hai Nhung},
  title = {HLM006474-mediated E2F1 inhibition suppresses fibrogenic activation in hepatic stellate cells: a preliminary in vitro study},
  journal = {Research Journal of Biotechnology},
  year = {2026},
  pages = {1},
  doi = {10.25303/2112rjbt01009}
}
Kostenlos starten →